Lymphoma Clinical Trials in Washington D.C., District of Columbia

5 studies are recruiting for lymphoma in Washington D.C., District of Columbia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

   The purpose of the study is to evaluate glofitamab + gemcitabine + oxaliplatin in participants in the United States, including under-represented racial and ethnic populations, that have relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL).

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Georgetown University, Washington D.C., District of Columbia

   Locations

   18 in total

   Run by

   Hoffmann-La Roche

   See if you can join NCT06624085 on ClinicalTrials.gov

2. A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

   The purpose of this study is to evaluate the efficacy of glofitamab monotherapy compared with an investigator's choice of either rituximab plus bendamustine (BR), or lenalidomide with rituximab (R-Len) in patients with relapsed or refractory (R/R) mantle cell lymphoma (MCL).

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Georgetown University, Washington D.C., District of Columbia

   Locations

   82 in total

   Run by

   Hoffmann-La Roche

   See if you can join NCT06084936 on ClinicalTrials.gov

3. A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

   The purpose of this study is to find out if mosunetuzumab is an effective treatment in people with follicular lymphoma that was recently diagnosed and have not yet received any treatments for their disease.

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Georgetown University (Data Collection Only), Washington D.C., District of Columbia

   Locations

   9 in total

   Run by

   Memorial Sloan Kettering Cancer Center

   See if you can join NCT05389293 on ClinicalTrials.gov

4. Mosaic Trial for Stem Cell Transplant Recipients

   The goal of this clinical trial is to learn if using an intervention website (Mosaic) improves selected patient-reported outcomes in adult blood cancer patients undergoing allogeneic or autologous stem cell transplant, compared to using an educational website (control group). Patients will be recru…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Georgetown University School of Medicine, Washington D.C., District of Columbia

   Locations

   3 in total

   Run by

   Northwestern University

   See if you can join NCT06960993 on ClinicalTrials.gov

5. Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

   This study collects blood and tissue samples for research of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)-related cancers. Collecting blood and tissue samples and studying biomarkers in the laboratory may help doctors to learn how are biologic or genetic factors rela…

   Stage

   Not phased

   Ages

   18 and older

   Site

   George Washington University, Washington D.C., District of Columbia

   Locations

   8 in total

   Run by

   AIDS Malignancy Consortium

   See if you can join NCT05663502 on ClinicalTrials.gov